FIELD: pharmaceutics.
SUBSTANCE: present invention relates to a novel peptide compound having an anti-inflammatory effect selected from Hyp-Gly-Gln-Glu-Leu-Leu-Ala, Hyp-Gly-Gln-Glu-Val-Leu-Ala and Hyp-Gly-Gln-Glu-Aib-Leu-Ala, or its pharmaceutically acceptable salt, as well as to its pharmaceutical, food and cosmetic composition.
EFFECT: novel peptide compound or its pharmaceutically acceptable salt is disclosed.
5 cl, 11 dwg, 2 tbl, 125 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW PEPTIDE AND PHARMACEUTICAL COMPOSITION FOR TREATMENT OF EYE DISEASE, CONTAINING PEPTIDE AS ACTIVE PHARMACEUTICAL INGREDIENT | 2018 |
|
RU2766160C2 |
| PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR TREATING EYE DISEASES | 2019 |
|
RU2819399C2 |
| METASTIN DERIVATIVES AND USE THEREOF | 2007 |
|
RU2454425C2 |
| PEPTIDE VECTORS | 2004 |
|
RU2361876C2 |
| PROTEINS WITH A DOUBLE FUNCTION AND A PHARMACEUTICAL COMPOSITION CONTAINING THEM | 2016 |
|
RU2741345C2 |
| PRODRUG COMPOSITIONS WITH HIGH DEGREE OF PENETRATION BASED ON PEPTIDES AND RELATED COMPOUNDS | 2010 |
|
RU2627065C2 |
| CYCLIC PEPTIDES OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS, A METHOD OF THEIR SYNTHESIS | 1992 |
|
RU2095368C1 |
| SYNTHESIS OF LIXISENATIDE WITH CAPPING | 2019 |
|
RU2782772C2 |
| HIGH-PENETRATION PRODRUG COMPOSITIONS BASED ON PEPTIDES AND PEPTIDE-RELATED COMPOUNDS | 2010 |
|
RU2767051C2 |
| OXYTOCIN RECEPTOR AGONISTS | 2010 |
|
RU2539692C2 |
